The paper discusses the non-anticoagulant properties of unfractionated heparin and enoxaparin and their relation to their chemical structures. It is emphasized that enoxaparin has multiple, often interrelated, non-anticoagulant effects that can complement its antithrombotic activity and enhance the efficiency of therapy in patients receiving the drug for various indications. The realization of these effects requires the complex structure with the standard distribution of molecular weight (Mw) (average Mw, about 4500 Da, as well as Mw of less than 2000 Da (68%), and more than 8000 Da (<18%), and with the standard content of 1.6-anhidro rings (15-25%), which is determined by the source of raw materials and by the production technology of the ...
Anticoagulant therapy with heparin has been the cornerstone of treatment and prevention of thrombosi...
Enoxaparin, a mixture of anticoagulant and non-anticoagulant fractions, is widely used as an anticoa...
Enoxaparin is a low-molecular weight heparin used to treat thrombotic disorders. Following the fatal...
The paper discusses the non-anticoagulant properties of unfractionated heparin and enoxaparin and th...
A low molecular weight heparin (enoxaparin, mean molecular weight ~ 4,400) was separated by gel chro...
The development of low-molecular and ultra-low-molecular weight heparins has changed anticoagulation...
[No abstract available]6635861Lindahl, U., Hook, M., Backstrom, G., Stricture and biosynthesis of he...
Enoxaparin, a complex, biologically derived low-molecular-weight heparin, is approved for a range of...
Enoxaparin, a complex, biologically derived low-molecular-weight heparin, is approved for a range of...
Our knowledge regarding chemical structure and properties of heparin and its derivatives, including ...
Background Enoxaparin treatment is associated with a 20 % reduction in clinical events during the ac...
preventthis complication. Clinicalstudiesperformedthroughoutthe world have shown that enoxaparinis s...
Heparin is a polypharmacological agent with anticoagulant activity. Periodate oxidation of the nonsu...
AbstractVarious branded low molecular weight heparins (LMWHs) have been used for the treatment and p...
Differences in the structure of three low molecular weight heparins (LMWHs) have been observed by ap...
Anticoagulant therapy with heparin has been the cornerstone of treatment and prevention of thrombosi...
Enoxaparin, a mixture of anticoagulant and non-anticoagulant fractions, is widely used as an anticoa...
Enoxaparin is a low-molecular weight heparin used to treat thrombotic disorders. Following the fatal...
The paper discusses the non-anticoagulant properties of unfractionated heparin and enoxaparin and th...
A low molecular weight heparin (enoxaparin, mean molecular weight ~ 4,400) was separated by gel chro...
The development of low-molecular and ultra-low-molecular weight heparins has changed anticoagulation...
[No abstract available]6635861Lindahl, U., Hook, M., Backstrom, G., Stricture and biosynthesis of he...
Enoxaparin, a complex, biologically derived low-molecular-weight heparin, is approved for a range of...
Enoxaparin, a complex, biologically derived low-molecular-weight heparin, is approved for a range of...
Our knowledge regarding chemical structure and properties of heparin and its derivatives, including ...
Background Enoxaparin treatment is associated with a 20 % reduction in clinical events during the ac...
preventthis complication. Clinicalstudiesperformedthroughoutthe world have shown that enoxaparinis s...
Heparin is a polypharmacological agent with anticoagulant activity. Periodate oxidation of the nonsu...
AbstractVarious branded low molecular weight heparins (LMWHs) have been used for the treatment and p...
Differences in the structure of three low molecular weight heparins (LMWHs) have been observed by ap...
Anticoagulant therapy with heparin has been the cornerstone of treatment and prevention of thrombosi...
Enoxaparin, a mixture of anticoagulant and non-anticoagulant fractions, is widely used as an anticoa...
Enoxaparin is a low-molecular weight heparin used to treat thrombotic disorders. Following the fatal...